Off-label intravenous thrombolysis for early recurrent brain embolism associated with aortic arch thrombus

1Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Safety data of intravenous thrombolysis (IVT) in presence of aortic arch thrombus is scant. Furthermore, IVT is debatable in patients with prior recent stroke. We present a 51-year-old woman with recurrent major infarction 5 days after a minor left MCA territory stroke. She had a floating aortic arch thrombus and she was treated safely and effectively with off-label IVT. Patients with small infarct volumes and mild/no residual neurological deficits after an initial stroke might be considered for IVT in case of early recurrence. IVT may be reasonable in a context of acute severely disabling stroke associated with aortic arch thrombus.

Cite

CITATION STYLE

APA

Koutroulou, I., Tsivgoulis, G., Rafailidis, V., Psoma, E., Kouskouras, K., Fotiadis, P., … Karapanayiotides, T. (2021, December 1). Off-label intravenous thrombolysis for early recurrent brain embolism associated with aortic arch thrombus. Neurological Research and Practice. BioMed Central Ltd. https://doi.org/10.1186/s42466-021-00103-6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free